Harvard Bioscience Return On Equity vs. Profit Margin
| HBIO Stock | USD 2.20 0.01 0.46% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (0.05) | Current Value (0.05) | Quarterly Volatility 0.08162036 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.4 | 0.5886 |
|
|
For Harvard Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Harvard Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Harvard Bioscience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Harvard Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Harvard Bioscience over time as well as its relative position and ranking within its peers.
Harvard |
Harvard Bioscience's Revenue Breakdown by Earning Segment
Check out Risk vs Return Analysis.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.33) | Revenue Per Share 2.258 | Quarterly Revenue Growth (0.13) | Return On Assets (0.02) |
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Harvard Bioscience Profit Margin vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Harvard Bioscience's current stock value. Our valuation model uses many indicators to compare Harvard Bioscience value to that of its competitors to determine the firm's financial worth. Harvard Bioscience is rated below average in return on equity category among its peers. It also is rated below average in profit margin category among its peers . At this time, Harvard Bioscience's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Harvard Bioscience's earnings, one of the primary drivers of an investment's value.Harvard Bioscience's Earnings Breakdown by Geography
Harvard Profit Margin vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Harvard Bioscience |
| = | -0.2 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Harvard Bioscience |
| = | (0.15) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Harvard Profit Margin Comparison
Harvard Bioscience is currently under evaluation in profit margin category among its peers.
Harvard Bioscience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Harvard Bioscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Harvard Bioscience will eventually generate negative long term returns. The profitability progress is the general direction of Harvard Bioscience's change in net profit over the period of time. It can combine multiple indicators of Harvard Bioscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -14.2 M | -13.5 M | |
| Operating Income | 1.9 M | 2 M | |
| Income Before Tax | -2.6 M | -2.7 M | |
| Total Other Income Expense Net | -4.5 M | -4.7 M | |
| Net Loss | -3.4 M | -3.6 M | |
| Income Tax Expense | 859 K | 807.3 K | |
| Net Loss | -8.6 M | -8.1 M | |
| Net Loss | -3.3 M | -3.4 M | |
| Non Operating Income Net Other | 271.8 K | 285.4 K | |
| Interest Income | 6.2 M | 6.5 M | |
| Net Interest Income | -3.7 M | -3.9 M | |
| Change To Netincome | 5.1 M | 3.4 M | |
| Net Loss | (0.08) | (0.08) | |
| Income Quality | (4.11) | (3.90) | |
| Net Income Per E B T | 1.34 | 1.40 |
Harvard Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Harvard Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Harvard Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Harvard Bioscience's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Harvard Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Use Investing Themes to Complement your Harvard Bioscience position
In addition to having Harvard Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Services Thematic Idea Now
Services
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
To fully project Harvard Bioscience's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Harvard Bioscience at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Harvard Bioscience's income statement, its balance sheet, and the statement of cash flows.